I. Elkonaissi

Investigating the efficacy of osimertinib and crizotinib in phase 3 clinical trials on anti-cancer treatment-induced cardiotoxicity: are real-world studies the way forward?

E. Foreman, S. Nabhani-Gebara, M. T. Dorak, 2022, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Management of COVID-19 in cancer patients receiving cardiotoxic anti-cancer therapy. Future recommendations for cardio-oncology

S. Nabhani-Gebara, M. T. Dorak, H. Kobat, 2021, Oncology reviews.

Impact of antimicrobial stewardship interventions on days of therapy and guideline adherence: A comparative point-prevalence survey assessment

A. Naqbi, D. Everett, Z. Babiker, 2023, Frontiers in Tropical Diseases.

Blastic plasmacytoid dendritic cell neoplasm: challenges in diagnosis and treatment with potential of venetoclax as an alternative to vincristine in high-risk patients—a case report

M. Damlaj, I. Mirza, I. Elkonaissi, 2023, Bulletin of the National Research Centre.